{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:49:43Z","timestamp":1791532183860,"version":"4.3.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 00"],"award-info":[{"award-number":["Finance Code 00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["403462\/2023-1"],"award-info":[{"award-number":["403462\/2023-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Ci\u00eancia e Tecnologia do Estado de Pernambuco","doi-asserted-by":"publisher","award":["APQ-0599-2.02\/14"],"award-info":[{"award-number":["APQ-0599-2.02\/14"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008132","name":"Universidade Federal de Pernambuco","doi-asserted-by":"publisher","award":["PROPG"],"award-info":[{"award-number":["PROPG"]}],"id":[{"id":"10.13039\/501100008132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Antiretroviral therapy suppresses HIV replication, but 10\u201340% of people living with HIV do not reconstitute CD4\u2009+\u2009T cell counts despite viral suppression. Cellular exhaustion and alteration in the frequency of CD4\u2009+\u2009T cell subsets are mechanisms involved in immunological nonresponse. This study investigated cellular exhaustion through gene expression and frequencies of CD4\u2009+\u2009T cell subpopulations through flow cytometry in 36 male individuals living with HIV (28 immunological responders and 8 immunological non-responders) after 18 months of treatment. Gene expression analysis revealed significantly upregulation of\n                    <jats:italic>PDCD1<\/jats:italic>\n                    (fold change\u2009=\u20091.81;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0003) and\n                    <jats:italic>TIGIT<\/jats:italic>\n                    (fold change\u2009=\u20091.80;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0055) in immunological non-responders compared to immunological responders, with ROC curve analysis confirming discriminatory ability. Flow cytometry demonstrated lower frequencies of recent thymic emigrant (19.42\u2009\u00b1\u20097.76 vs. 32.29\u2009\u00b1\u200910.68;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0285) and naive CD4\u2009+\u2009T cells (26.10\u2009\u00b1\u20099.41 vs. 47.65\u2009\u00b1\u200913.45;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0194) in immunological non-responders compared to immunological responders. Moreover, we observed higher frequency of central memory CD4\u2009+\u2009T cells (47.94\u2009\u00b1\u200913.42 vs. 32.58\u2009\u00b1\u20099.89;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0184), with excellent discriminatory capacity.\n                    <jats:italic>TIGIT<\/jats:italic>\n                    expression inversely correlated with recent thymic emigrant (\n                    <jats:italic>r<\/jats:italic>\n                    = -0.7284;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0013) and naive CD4\u2009+\u2009T cells (\n                    <jats:italic>r<\/jats:italic>\n                    = -0.7394;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0010), and directly with central memory CD4\u2009+\u2009T cells (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.7264;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0014). These findings emphasize cellular exhaustion and dysregulated CD4\u2009+\u2009T cell subsets as critical factors of immunological nonresponse.\n                  <\/jats:p>","DOI":"10.1007\/s12026-026-09859-y","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:07:15Z","timestamp":1791529635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Upregulation of cellular exhaustion-related genes and CD4\u2009+\u2009T cell disturbances in immunological non-responders on antiretroviral therapy"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1162-5426","authenticated-orcid":false,"given":"Henrique Fernando","family":"Lopes-Araujo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wlisses Henrique Veloso","family":"Carvalho-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Leandro","family":"Andrade-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carolina Santos","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabr\u00edcio Oliveira","family":"Souto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Cl\u00e1udio Arraes","family":"De Alencar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"de Farias Domingos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo S\u00e9rgio Ramos","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleyverson","family":"Feliciano-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Lima","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"9859_CR1","unstructured":"Vijayan KV, Karthigeyan KP, Tripathi SP, Hanna LE. Pathophysiology of CD4\u2009+\u2009T-Cell depletion in HIV-1 and HIV-2 infections. Front. Immunol. Frontiers Media S.A. 2017."},{"key":"9859_CR2","doi-asserted-by":"crossref","unstructured":"Chen B. Molecular mechanism of HIV-1 Entry. Trends Microbiol. Elsevier Ltd. 2019:878\u201391.","DOI":"10.1016\/j.tim.2019.06.002"},{"key":"9859_CR3","doi-asserted-by":"crossref","unstructured":"Chiao EY, Coghill A, Kizub D, Fink V, Ndlovu N, Mazul A et al. The effect of non-AIDS-defining cancers on people living with HIV. Lancet Oncol. Lancet Publishing Group. 2021:240\u201353.","DOI":"10.1016\/S1470-2045(21)00137-6"},{"key":"9859_CR4","doi-asserted-by":"crossref","unstructured":"Laksemi DA, Suwanti LT, Suwanti LT, Mufasirin M, Mufasirin M, Suastika K et al. Opportunistic parasitic infections in patients with human immunodeficiency virus\/acquired immunodeficiency syndrome: a review. Vet. World. Veterinary World. 2020:716\u201325.","DOI":"10.14202\/vetworld.2020.716-725"},{"key":"9859_CR5","unstructured":"World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. 2021."},{"key":"9859_CR6","doi-asserted-by":"crossref","unstructured":"Thoueille P, Choong E, Cavassini M, Buclin T, Decosterd LA. Long-acting antiretrovirals: A new era for the management and prevention of HIV infection. Journal of Antimicrobial Chemotherapy. Oxford University Press. 2022:290\u2013302.","DOI":"10.1093\/jac\/dkab324"},{"key":"9859_CR7","doi-asserted-by":"crossref","unstructured":"Taramasso L, Labate L, Briano F, Brucci G, Mora S, Blanchi S et al. CD4\u2009+\u2009T lymphocyte recovery in the modern antiretroviral therapy era: toward a new threshold for defining immunological non-responders. Front Virol Front Media SA; 2022:2.","DOI":"10.3389\/fviro.2022.822153"},{"key":"9859_CR8","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.2147\/IDR.S522910","volume":"18","author":"J Ji","year":"2025","unstructured":"Ji J, Guo C, Li Z, Cai M, Wang R, Chen X, et al. Rapid initiation of antiretroviral therapy suppresses T cell pathological proliferation and improves immune recovery in people living with HIV. Infect Drug Resist Dove Medical Press Ltd. 2025;18:3427\u201337.","journal-title":"Infect Drug Resist Dove Medical Press Ltd<br>"},{"key":"9859_CR9","doi-asserted-by":"crossref","unstructured":"Yang X, Su B, Zhang X, Liu Y, Wu H, Zhang T. Incomplete immune reconstitution in HIV\/AIDS patients on antiretroviral therapy: challenges of immunological non-responders. J. Leukoc. Biol. John Wiley and Sons Inc. 2020:597\u2013612.","DOI":"10.1002\/JLB.4MR1019-189R"},{"key":"9859_CR10","doi-asserted-by":"crossref","unstructured":"Zhang W, Ruan L. Recent advances in poor HIV immune reconstitution: what will the future look like? Front. Microbiol. Frontiers Media SA. 2023.","DOI":"10.3389\/fmicb.2023.1236460"},{"key":"9859_CR11","unstructured":"Bono V, Augello M, Tincati C, Marchetti G. Failure of CD4\u2009+\u2009T-cell recovery upon virally-effective cART: an enduring gap in the understanding of HIV+ immunological non-responders. New Microbiologica. 2022."},{"key":"9859_CR12","doi-asserted-by":"crossref","unstructured":"Carvalho-Silva WHV, Andrade-Santos JL, Dos Santos Guedes MC, Guimar\u00e3es RL. Genetics and immunological recovery with antiretroviral treatment for HIV. Pharmacogenomics. Future Medicine Ltd. 2020:979\u201383.","DOI":"10.2217\/pgs-2020-0083"},{"key":"9859_CR13","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3390\/biomedicines13081839","volume":"13","author":"D Vangelov","year":"2025","unstructured":"Vangelov D, Emilova R, Todorova Y, Yancheva N, Dimitrova R, Grigorova L, et al. T-lymphocyte phenotypic and mitochondrial parameters as markers of incomplete immune restoration in people living with HIV\u2009+\u2009on long-term cART. Biomedicines MDPI AG. 2025;13:1839.","journal-title":"Biomedicines MDPI AG"},{"key":"9859_CR14","doi-asserted-by":"crossref","unstructured":"Cai CW, Sereti I. Residual immune dysfunction under antiretroviral therapy. Semin. Immunol. Academic Press. 2021.","DOI":"10.1016\/j.smim.2021.101471"},{"key":"9859_CR15","doi-asserted-by":"crossref","unstructured":"Teer E, Mukonowenzou NC, Essop MF. HIV, inflammation, and immunometabolism: a model of the inflammatory theory of disease. Viruses. Multidisciplinary Digital Publishing Institute (MDPI). 2025.","DOI":"10.3390\/v17060839"},{"key":"9859_CR16","doi-asserted-by":"crossref","unstructured":"Hu Y, Zhang Y, Shi F, Yang R, Yan J, Han T, et al. Reversal of T-cell exhaustion: Mechanisms and synergistic approaches. Int. Immunopharmacol. Elsevier B.V. 2024.","DOI":"10.1016\/j.intimp.2024.112571"},{"key":"9859_CR17","doi-asserted-by":"crossref","unstructured":"Zhao J, Schank M, Wang L, Li Z, Nguyen LN, Dang X, et al. Mitochondrial functions are compromised in CD4 T cells from ART-controlled PLHIV. Front Immunol. Frontiers Media S.A. 2021:12.","DOI":"10.3389\/fimmu.2021.658420"},{"key":"9859_CR18","first-page":"1799","volume":"213","author":"SJ Hwang","year":"2016","unstructured":"Hwang SJ, Cobb DA, Bhadra R, Youngblood B, Khan IA. Blimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis. J Experimental Med Rockefeller Univ Press. 2016;213:1799\u2013818.","journal-title":"J Experimental Med Rockefeller Univ Press"},{"key":"9859_CR19","doi-asserted-by":"crossref","unstructured":"Saeidi A, Zandi K, Cheok YY, Saeidi H, Wong WF, Lee CYQ, et al. T-cell exhaustion in chronic infections: reversing the state of exhaustion and reinvigorating optimal protective immune responses. Front Immunol. Frontiers Media S.A. 2018:9.","DOI":"10.3389\/fimmu.2018.02569"},{"key":"9859_CR20","doi-asserted-by":"crossref","unstructured":"Yan L, Xu K, Xiao Q, Tuo L, Luo T, Wang S, et al. Cellular and molecular insights into incomplete immune recovery in HIV\/AIDS patients. Front. Immunol. Frontiers Media S.A. 2023.","DOI":"10.3389\/fimmu.2023.1152951"},{"key":"9859_CR21","doi-asserted-by":"crossref","unstructured":"Lorvik KB, Meyer-Myklestad MH, Kushekar K, Handeland C, Medhus AW, Lund-Iversen M, et al. Enhanced gut-homing dynamics and pronounced exhaustion of mucosal and blood CD4\u2009+\u2009T Cells in HIV-infected immunological non-responders. Front Immunol. Frontiers Media S.A. 2021:12.","DOI":"10.3389\/fimmu.2021.744155"},{"key":"9859_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/v14030581","volume-title":"Expression Profile and Biological Role of Immune Checkpoints in Disease Progression of HIV\/SIV Infection","author":"Y Sun","year":"2022","unstructured":"Sun Y, Xue J. Expression profile and biological role of immune checkpoints in disease progression of HIV\/SIV infection. Viruses: MDPI. 2022."},{"key":"9859_CR23","doi-asserted-by":"crossref","unstructured":"Wagner M, Jasek M, Karabon L. Immune checkpoint molecules\u2014inherited variations as markers for cancer risk. Front. Immunol. Frontiers Media S.A. 2021.","DOI":"10.3389\/fimmu.2020.606721"},{"key":"9859_CR24","doi-asserted-by":"crossref","unstructured":"Cenderello G, De Maria A. Discordant responses to cART in HIV-1 patients in the era of high potency antiretroviral drugs: Clinical evaluation, classification, management prospects. Expert Rev. Anti. Infect. Ther. Taylor and Francis Ltd; 2016:29\u201340.","DOI":"10.1586\/14787210.2016.1106937"},{"key":"9859_CR25","first-page":"634","volume":"71","author":"SA Bustin","year":"2025","unstructured":"Bustin SA, Ruijter JM, van den Hoff MJB, Kubista M, Pfaffl MW, Shipley GL, et al. MIQE 2.0: revision of the minimum information for publication of quantitative real-time pcr experiments guidelines. Clin Chem. Oxford University Press (OUP). 2025;71:634\u201351.","journal-title":"Clin Chem. Oxford University Press (OUP)<br>"},{"key":"9859_CR26","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","volume":"126","author":"P Schober","year":"2018","unstructured":"Schober P, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg Lippincott Williams Wilkins. 2018;126:1763\u20138.","journal-title":"Anesth Analg Lippincott Williams Wilkins"},{"key":"9859_CR27","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","volume":"5","author":"JN Mandrekar","year":"2010","unstructured":"Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5:1315\u20136.","journal-title":"J Thorac Oncol"},{"key":"9859_CR28","doi-asserted-by":"crossref","unstructured":"Cohen J. A Power Primer. Quantitative methods in psychology. 1992.","DOI":"10.1037\/0033-2909.112.1.155"},{"key":"9859_CR29","doi-asserted-by":"crossref","unstructured":"Fenwick C, Joo V, Jacquier P, Noto A, Banga R, Perreau M, et al. T-cell exhaustion in HIV infection. Immunol. Rev. Blackwell Publishing Ltd. 2019:149\u201363.","DOI":"10.1111\/imr.12823"},{"key":"9859_CR30","doi-asserted-by":"crossref","unstructured":"Sharpe AH, Pauken KE. The diverse functions of the PD1 inhibitory pathway. Nat Rev Immunol Nat Publishing Group. 2018:153\u201367.","DOI":"10.1038\/nri.2017.108"},{"key":"9859_CR31","doi-asserted-by":"crossref","unstructured":"Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren HG, S\u00f6nnerborg A et al. Perturbed CD8\u2009+\u2009T cell TIGIT\/CD226\/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep Nat Publishing Group. 2017:7.","DOI":"10.1038\/srep40354"},{"key":"9859_CR32","doi-asserted-by":"crossref","unstructured":"Aksak-W\u0105s B, Skonieczna-\u017bydecka K, Parczewski M, Hrynkiewicz R, Lewandowski F, Serwin K, et al. Immunorecovered but exhausted: persistent PD-1\/PD-L1 expression despite virologic suppression and CD4 Recovery in PLWH. Biomedicines. Multidisciplinary Digital Publishing Institute (MDPI). 2025:13.","DOI":"10.3390\/biomedicines13081885"},{"key":"9859_CR33","doi-asserted-by":"crossref","unstructured":"Jimnez VC, Wit FWNM, Joerink M, Maurer I, Harskamp AM, Schouten J, et al. T-cell activation independently associates with immune senescence in hiv-infected recipients of long-term antiretroviral treatment. Journal of Infectious Diseases. Oxford University Press. 2016;214:216\u201325.","DOI":"10.1093\/infdis\/jiw146"},{"key":"9859_CR34","doi-asserted-by":"crossref","unstructured":"Dos Santos Guedes MC, Carvalho-Silva WHV, Andrade-Santos JL, Brelaz-de-Castro MCA, Souto FO, Guimar\u00e3es RL. Thymic exhaustion and increased immune activation are the main mechanisms involved in impaired immunological recovery of HIV-positive patients under ART. Viruses. MDPI. 2023:15.","DOI":"10.3390\/v15020440"},{"key":"9859_CR35","doi-asserted-by":"crossref","unstructured":"Jubel JM, Barbati ZR, Burger C, Wirtz DC, Schildberg FA. The role of PD-1 in acute and chronic infection. Front. Immunol. Frontiers Media S.A. 2020.","DOI":"10.3389\/fimmu.2020.00487"},{"key":"9859_CR36","doi-asserted-by":"crossref","unstructured":"Chew GM, Fujita T, Webb GM, Burwitz BJ, Wu HL, Reed JS, et al. TIGIT marks exhausted T cells, correlates with disease progression, and serves as a target for immune restoration in hiv and siv infection. plos pathog. public library of science. 2016:12","DOI":"10.1371\/journal.ppat.1005349"},{"key":"9859_CR37","first-page":"776","volume":"47","author":"CS McGary","year":"2017","unstructured":"McGary CS, Deleage C, Harper J, Micci L, Ribeiro SP, Paganini S, et al. CTLA-4\u2009+\u2009PD-1\u2009\u2013\u2009memory CD4\u2009+\u2009T cells critically contribute to viral persistence in antiretroviral therapy-suppressed, SIV-infected rhesus macaques. Immun Cell Press. 2017;47:776\u2013e7885.","journal-title":"Immun Cell Press"},{"key":"9859_CR38","doi-asserted-by":"crossref","unstructured":"Huang Y, Dhummakupt A, Khetan P, Nilles T, Zhou W, Mudvari P, et al. Immune activation and exhaustion marker expression on T-cell subsets in ART-treated adolescents and young adults with perinatal HIV-1 infection as correlates of viral persistence. Front Immunol. Frontiers Media S.A. 2023:14.","DOI":"10.3389\/fimmu.2023.1007626"},{"key":"9859_CR39","doi-asserted-by":"crossref","unstructured":"Rasmussen TA, Rajdev L, Rhodes A, Dantanarayana A, Tennakoon S, Chea S, et al. Impact of anti-PD-1 and anti-CTLA-4 on the human immunodeficiency virus (HIV) reservoir in people living with HIV with cancer on antiretroviral therapy: the AIDS malignancy consortium 095 study. Clinical Infectious Diseases. Oxford University Press. 2021;73:E1973\u201381.","DOI":"10.1093\/cid\/ciaa1530"},{"key":"9859_CR40","doi-asserted-by":"crossref","unstructured":"Zhao H, Feng A, Luo D, Yuan T, Lin YF, Ling X, et al. Factors associated with immunological non-response after ART initiation: a retrospective observational cohort study. Volume 24. BMC Infect Dis. BioMed Central Ltd; 2024.","DOI":"10.1186\/s12879-024-09021-9"},{"key":"9859_CR41","doi-asserted-by":"crossref","unstructured":"Ron R, Mart\u00ednez-Sanz J, Herrera S, Ramos-Ruperto L, D\u00edez A, Sainz T, et al. CD4\/CD8 ratio and CD8\u2009+\u2009T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis. Front. Immunol. Frontiers Media SA. 2024.","DOI":"10.2139\/ssrn.4579870"},{"key":"9859_CR42","unstructured":"Sainz T, Serrano-Villar S, D\u00edaz L, Isabel Gonz\u00e1lez Tom\u00e9 M, Dolores Gurbindo M, Isabel de Jos\u00e9 M et al. The CD4\/CD8 ratio as a marker T-cell activation, senescence and activation\/exhaustion in treated HIV-infected children and young adults."},{"key":"9859_CR43","doi-asserted-by":"crossref","unstructured":"Brice\u00f1o O, Ch\u00e1vez-Torres M, Peralta-Prado A, Garrido-Rodr\u00edguez D, Romero-Mora K, Pinto-Cardoso S, et al. Associations between recent thymic emigrants and CD4\u2009+\u2009T-cell recovery after short-term antiretroviral therapy initiation. AIDS. Lippincott Williams and Wilkins. 2020;34:501\u201311.","DOI":"10.1097\/QAD.0000000000002458"},{"key":"9859_CR44","doi-asserted-by":"crossref","unstructured":"Xiao Q, Yan L, Han J, Yang S, Tang Y, Li Q, et al. Metabolism-dependent ferroptosis promotes mitochondrial dysfunction and inflammation in CD4\u2009+\u2009T lymphocytes in HIV-infected immune non-responders. EBioMedicine. Elsevier B.V. 2022:86.","DOI":"10.1016\/j.ebiom.2022.104382"},{"key":"9859_CR45","doi-asserted-by":"crossref","unstructured":"Song CB, Zhang L, Le, Wu X, Fu YJ, Jiang YJ, Shang H et al. CD4\u2009+\u2009CD38+ central memory T cells contribute to HIV persistence in HIV-infected individuals on long-term ART. J Transl Med. BioMed Central Ltd. 2020:18.","DOI":"10.1186\/s12967-020-02245-8"},{"key":"9859_CR46","doi-asserted-by":"crossref","unstructured":"Raphael I, Joern RR, Forsthuber TG. Memory CD4\u2009+\u2009T cells in immunity and autoimmune diseases. Cells. NLM (Medline). 2020.","DOI":"10.3390\/cells9030531"},{"key":"9859_CR47","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.immuni.2014.01.005","volume":"40","author":"A Crawford","year":"2014","unstructured":"Crawford A, Angelosanto JM, Kao C, Doering TA, Odorizzi PM, Barnett BE, et al. Molecular and transcriptional basis of CD4\u2009+\u2009T cell dysfunction during chronic infection. Immunity. 2014;40:289\u2013302.","journal-title":"Immunity"},{"key":"9859_CR48","doi-asserted-by":"crossref","unstructured":"Wykes MN, Lewin SR. Immune checkpoint blockade in infectious diseases. Nat Rev Immunol Nat Publishing Group. 2018:91\u2013104.","DOI":"10.1038\/nri.2017.112"},{"key":"9859_CR49","doi-asserted-by":"crossref","unstructured":"Fromentin R, Bakeman W, Lawani MB, Khoury G, Hartogensis W, DaFonseca S, et al. CD4\u2009+\u2009T cells expressing PD-1, TIGIT and LAG-3 contribute to HIV persistence during ART. PLoS Pathog. Public Library of Science. 2016;12.","DOI":"10.1371\/journal.ppat.1005761"},{"key":"9859_CR50","doi-asserted-by":"crossref","unstructured":"Rasmussen TA, Zerbato JM, Rhodes A, Tumpach C, Dantanarayana A, McMahon JH et al. Memory CD4\u2009+\u2009T cells that co-express PD1 and CTLA4 have reduced response to activating stimuli facilitating HIV latency. Cell Rep Med. Cell Press. 2022;3.","DOI":"10.1016\/j.xcrm.2022.100766"},{"key":"9859_CR51","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1158\/1078-0432.CCR-16-0933","volume":"22","author":"SJ Blake","year":"2016","unstructured":"Blake SJ, Dougall WC, Miles JJ, Teng MWL, Smyth MJ, American association for cancer research Inc. Molecular pathways: targeting CD96 and TIGIT for cancer immunotherapy. Clin Cancer Res. 2016;22:5183\u20138.","journal-title":"Clin Cancer Res"},{"key":"9859_CR52","doi-asserted-by":"crossref","unstructured":"McCulloch TR, Rossi GR, Miranda-Hernandez S, Valencia-Hernandez AM, Alim L, Belle CJ et al. The immune checkpoint TIGIT is upregulated on T cells during bacterial infection and is a potential target for immunotherapy. Immunol Cell Biol. John Wiley and Sons Inc; 2024;102:721\u201333.","DOI":"10.1111\/imcb.12794"},{"key":"9859_CR53","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s00262-021-02886-8","volume":"70","author":"R Liang","year":"2021","unstructured":"Liang R, Zhu X, Lan T, Ding D, Zheng Z, Chen T, et al. TIGIT promotes CD8\u2009+\u2009T cells exhaustion and predicts poor prognosis of colorectal cancer. Cancer Immunol Immunotherapy Springer Sci Bus Media Deutschland GmbH. 2021;70:2781\u201393.","journal-title":"Cancer Immunol Immunotherapy Springer Sci Bus Media Deutschland GmbH"},{"key":"9859_CR54","doi-asserted-by":"crossref","unstructured":"Chauvin JM, Ka M, Pagliano O, Menna C, Ding Q, DeBlasio R, et al. IL15 stimulation with TIGIT blockade reverses CD155-mediated NK-Cell dysfunction in Melanoma. Clinical Cancer Research. American Association for Cancer Research Inc. 2020;26:5520\u201333.","DOI":"10.1158\/1078-0432.CCR-20-0575"},{"key":"9859_CR55","doi-asserted-by":"crossref","unstructured":"Liu L, Wang A, Liu X, Han S, Sun Y, Zhang J et al. Blocking TIGIT\/CD155 signalling reverses CD8\u2009+\u2009T cell exhaustion and enhances the antitumor activity in cervical cancer. J Transl Med. BioMed Central Ltd. 2022;20.","DOI":"10.1186\/s12967-022-03480-x"},{"key":"9859_CR56","doi-asserted-by":"crossref","unstructured":"Pino M, Ribeiro SP, Pagliuzza A, Ghneim K, Khan A, Ryan E et al. Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART. PLoS Pathog Public Libr Sci. 2021;17.","DOI":"10.1371\/journal.ppat.1009825"},{"key":"9859_CR57","doi-asserted-by":"crossref","unstructured":"Vendrame E, Seiler C, Ranganath T, Zhao NQ, Vergara R, Alary M, et al. TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells. Volume 34. AIDS. Lippincott Williams and Wilkins. 2020:801\u201313.","DOI":"10.1097\/QAD.0000000000002488"},{"key":"9859_CR58","doi-asserted-by":"crossref","unstructured":"Shive CL, Freeman ML, Younes SA, Kowal CM, Canaday DH, Rodriguez B, et al. Markers of T cell exhaustion and senescence and their relationship to plasma TGF-\u03b2 levels in treated HIV+ immune non-responders. Front Immunol. Frontiers Media S.A. 2021:12.","DOI":"10.3389\/fimmu.2021.638010"},{"key":"9859_CR59","doi-asserted-by":"crossref","unstructured":"Maksimova A, Tyrinova T, Chernykh E. TIM-3\u2009+\u2009Macrophages: insights into their role in cancer and inflammation. Int. J. Mol. Sci. Multidisciplinary Digital Publishing Institute (MDPI). 2026.","DOI":"10.3390\/ijms27020840"},{"key":"9859_CR60","doi-asserted-by":"crossref","unstructured":"Sabins NC, Harman BC, Barone LR, Shen S, Santulli-Marotto S. Differential expression of immune checkpoint modulators on in vitro primed CD4\u2009+\u2009and CD8\u2009+\u2009T cells. Front Immunol Front Res Foundation. 2016;7.","DOI":"10.3389\/fimmu.2016.00221"},{"key":"9859_CR61","doi-asserted-by":"crossref","unstructured":"Zhai Y, Celis-Gutierrez J, Voisinne G, Mori D, Girard L, Burlet-Schiltz O et al. Opposing regulatory functions of the TIM3 (HAVCR2) signalosome in primary effector T cells as revealed by quantitative interactomics. Cell. Mol. Immunol. Springer Nature. 2021:1581\u20133.","DOI":"10.1038\/s41423-020-00575-7"},{"key":"9859_CR62","doi-asserted-by":"crossref","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol Nat Publishing Group. 2016:626\u201338.","DOI":"10.1038\/nri.2016.90"},{"key":"9859_CR63","first-page":"349","volume":"73","author":"JL Andrade-Santos","year":"2021","unstructured":"Andrade-Santos JL, Carvalho-Silva WHV, Souto FO, Crovella S, Guimar\u00e3es RL. Differences in pyroptosis of recent thymic emigrants CD4\u2009+\u2009T Lymphocytes in ART-treated HIV-positive patients are influenced by sex. Immunogenet Springer Sci Bus Media Deutschland GmbH. 2021;73:349\u201353.","journal-title":"Immunogenet Springer Sci Bus Media Deutschland GmbH"},{"key":"9859_CR64","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.celrep.2018.06.054","volume":"24","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Harrison DL, Song Y, Ji J, Huang J, Hui E. Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells. Cell Rep Elsevier B V. 2018;24:379\u2013e3906.","journal-title":"Cell Rep Elsevier B V"},{"key":"9859_CR65","doi-asserted-by":"crossref","unstructured":"Manieri NA, Chiang EY, Grogan JL. TIGIT: a key inhibitor of the cancer immunity cycle. Trends Immunol. Elsevier Ltd. 2017:20\u20138.","DOI":"10.1016\/j.it.2016.10.002"},{"key":"9859_CR66","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jiph.2017.08.001","volume":"11","author":"M Darraj","year":"2018","unstructured":"Darraj M, Shafer LA, Chan S, Kasper K, Keynan Y. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression. J Infect Public Health Elsevier Ltd. 2018;11:265\u20139.","journal-title":"J Infect Public Health Elsevier Ltd"},{"key":"9859_CR67","first-page":"2683","volume":"129","author":"FP Guo","year":"2016","unstructured":"Guo FP, Li YJ, Qiu ZF, Lv W, Han Y, Xie J, et al. Baseline naive CD4\u2009+\u2009T-cell level predicting immune reconstitution in treated HIV-infected late presenters. Chin Med J (Engl) Chin Med Association. 2016;129:2683\u201390.","journal-title":"Chin Med J (Engl) Chin Med Association"},{"key":"9859_CR68","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1086\/651689","volume":"50","author":"E Negredo","year":"2010","unstructured":"Negredo E, Massanella M, Puig J, P\u00e9rez-\u00c1lvarez N, Gallego-Escuredo JM, Villarroya J, et al. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: Clinical implications. Clin Infect Dis. 2010;50:1300\u20138.","journal-title":"Clin Infect Dis"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09859-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09859-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09859-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:07:22Z","timestamp":1791529642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09859-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9859"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09859-y","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"26 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committees of HCP (protocol 77566023.5.0000.5190); HC-UFPE and IMIP (protocol 65468222.3.1001.8807). Moreover, the research was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"125"}}